Stage (next event)
Phase 3 (Initiation)
Catalyst Info & Data Links
TITLE: VXA-A1.1 for Seasonal Influenza - Phase 3 Initiation
ClinicalTrial.gov (NCT02918006): A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine
WHAT IS THE CATALYST EVENT?
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
2020: Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. The Lancet Infectious Diseases.
Updated by HC
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post